st-100
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started May 17, 2021 (NCT05241470)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06178679 | Phase 3 | Jan 2, 2024 | ORA, Inc., Stuart Therapeutics, Inc. |
| NCT05241470 | Phase 2 | May 17, 2021 | ORA, Inc., Stuart Therapeutics, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ORA, Inc. | For profit | 2 | 1 | 2 | 2021 |
| Stuart Therapeutics, Inc. | For profit | 2 | 1 | 2 | 2021 |
2 organizations
Page 1 / 1